|
|
Volumn 48, Issue 6, 2008, Pages 247-248
|
|
Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: Sub-analysis of the post-marketing surveillance study: Commentary
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FASUDIL;
OZAGREL;
BLEEDING;
COMBINATION CHEMOTHERAPY;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
HYPOTENSION;
MONOTHERAPY;
NOTE;
POSTMARKETING SURVEILLANCE;
SUBARACHNOID HEMORRHAGE;
TREATMENT OUTCOME;
UNSPECIFIED SIDE EFFECT;
VASOSPASM;
|
|
EID: 45849091055
PISSN: 04708105
EISSN: 13498029
Source Type: Journal
DOI: 10.2176/nmc.48.241 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
